期刊语言：英语

出版地区：英国

万维提示

1、投稿方式：在线投稿。

2、期刊网址：

https://www.journals.elsevier.com/journal-of-comparative-pathology/

3、投稿网址：

https://www.editorialmanager.com/YJCPA

4、期刊刊期：一年出版8期。

2021年6月30日星期三

投稿须知【官网信息】

Guide for Authors

Notes for Contributors

Scope

The Journal of Comparative Pathology exists to publish articles recording research and original scientific findings relevant to the diseases of domesticated and other vertebrate animals. Articles on diseases of man are also appropriate if they present features of special interest when viewed against the general background of vertebrate pathology.

In addition, the Journal may publish Short Papers. These are intended to include reports of small completed investigations, new techniques or case descriptions. They should not have the subdivisions of a full length paper, but should include a brief summary and essential references. They would normally not exceed a word limit of 2000 and should include no more than four supportive figures (as individual images not composites of multiple images) or tables. Such submissions should be clearly marked 'Short Paper'. Single case reports will be accepted only if they make a significant contribution to knowledge.

The Journal publishes Review Articles on topics of broad interest from invited authors with acknowledged expertise in their field. Unsolicited Review Articles will be considered, but authors intending to prepare a review should first contact the Editor-in-Chief to discuss their proposal for a review article.

The Journal will publish ‘Mini Reviews’ on topical subjects that fall within the overall scope of the Journal. A Mini Review will summarize in succinct fashion the key points related to (for example) the pathogenesis and pathology of a disease process and provide a ‘cutting edge’ overview of current research and future research directions related to that disease or subject area. Mini Reviews will normally be commissioned by the Editor of the Journal, but unsolicited contributions will be considered and subjected to the normal peer review process.

• A Mini Review will be restricted to a 1,750 to 2,000 word limit (not including summary and references) and key points may be made by the use of bullet points.

• A Mini Review will be supported by no more than 10 key current references. References need not be cited within the text in standard Journal format, but can appear as a list of ‘Key References’.

• A Mini Review should be supported by between four to six photographic images (e.g. of gross or microscopical pathology or diagrammatic summaries of key disease mechanisms).

• A Mini Review must have a standard Summary (abstract) with four suggested key words.

• A Mini Review should follow the general Journal format for title, authors and affiliations, reference and citation style, acknowledgments and Conflict of Interest Statement as detailed within the Notes for Contributors.

The Journal of Comparative Pathology offers an online platform for the journal?s international community of readers, authors, editors and editorial advisers to comment on topical issues related to veterinary pathology.

Submissions to `Pathology Matters? should comprise substantive, concise and focussed commentary that is clear, compelling and attractive to our international readership of scientists in the veterinary and wider life science disciplines.

Contributions that are well argued and clearly written within the 600-word limit, are more likely to be accepted.

Comment pieces should have a concise and appealing title. Up to five references, preferably as hyperlinks within the text, can be included if necessary. If urls cannot be provided for references, they can be typed at the end of the piece in the format of the Journal of Comparative Pathology. Authors should provide a one- or two-sentence biography at the end of the piece to identify themselves. A recent high quality portrait photograph of the lead author may also be submitted to accompany the article, as well as their Twitter handle if desired.

Comment pieces will not be subject to peer review but will be published, edited or rejected at the discretion of the Editor. It is a condition of submission that authors accept that contributions to Pathology Matters can be edited and published online without the approval of the author.

Please read the journal?s policy on competing interests and add the appropriate statement from this document to your article. Page charges

This journal has no page charges.

Ethics in publishing

Please see our information on Ethics in publishing.

Animal Experimentation

Circumstances relating to animal experimentation must meet the International Guiding Principles for Biomedical Research Involving Animals as issued by the Council for the International Organizations of Medical Sciences. They are obtainable from: Executive Secretary C.I.O.M.S., c/o WHO, Via Appia, CH-1211 Geneva 27, Switzerland, or at the following URL: http://www.cioms.ch/publications/guidelines/1985_texts_of_guidelines.htm. Such studies must meet Animals in Research: Reporting In Vivo Experiments (ARRIVE) guidelines (https://www.elsevier.com/__data/promis_misc/ARRIVE.pdf). Unnecessary suffering in animal experimentation is not acceptable to the Editors of the Journal of Comparative Pathology. Authors must indicate the nature of ethical approval for a study in the appropriate section of the Materials and Methods of a manuscript.

Declaration of interest

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.

Conditions of Acceptance

The Editorial Board accepts papers on the understanding that they have not been published elsewhere and, if accepted, will not be reprinted in whole or in part without the Board's written approval. The Board reserves the right to reject, on scientific, ethical or other grounds, any manuscript submitted to it. Each person named in the list of authors of a paper must have made a substantial scientific or critical contribution to the work described and have read and approved the version submitted to the Journal.

Papers will be published with the minimum of delay, bearing the dates of receipt and acceptance. The period between receipt of an article and publication depends on the amount of editorial work and correspondence required and the number of articles already awaiting publication. Exceptionally, the Editor may use discretion in determining whether a degree of accelerated publication could be offered.

Use of inclusive language

Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.

Author contributions

For transparency, we encourage authors to submit an author statement file outlining their individual contributions to the paper using the relevant CRediT roles: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing - original draft; Writing - review & editing. Authorship statements should be formatted with the names of authors first and CRediT role(s) following. More details and an example

Article transfer service

This journal is part of our Article Transfer Service. This means that if the Editor feels your article is more suitable in one of our other participating journals, then you may be asked to consider transferring the article to one of those. If you agree, your article will be transferred automatically on your behalf with no need to reformat. Please note that your article will be reviewed again by the new journal. More information.

Copyright

Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.

Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases.

For gold open access articles: Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (more information). Permitted third party reuse of gold open access articles is determined by the author's choice of user license.

Author rights

As an author you (or your employer or institution) have certain rights to reuse your work. More information.

Role of the funding source

You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.

Open access (OA)

This journal offers authors a choice in publishing their research:

Open Access

• Articles are freely available to both subscribers and the wider public with permitted reuse

• An open access publication fee is payable by authors or their research funder

Please visit our Open Access page for more information.

Subscription

• Articles are made available to subscribers as well as developing countries and patient groups through our access programs

• No open access publication fee

All articles published open access will be immediately and permanently free for everyone to read and download. Permitted reuse is defined by your choice of one of the following Creative Commons user licenses:

Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND): for non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.

Elsevier has established agreements with funding bodies, https://www.elsevier.com/fundingbodies. This ensures authors can comply with funding body open access requirements, including specific user licenses, such as CC BY. Some authors may also be reimbursed for associated publication fees. If you need to comply with your funding body policy, you can apply for the CC BY license after your manuscript is accepted for publication.

To provide open access, this journal has a publication fee which needs to be met by the authors or their research funders for each article published open access.

Your publication choice will have no effect on the peer review process or acceptance of submitted articles.

Language services

The Journal of Comparative Pathology is published in British and not American English. Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's WebShop https://webshop.elsevier.com/language-editing-services/language-editing/ or visit our customer support site https://service.elsevier.com for more information.

Submission

Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.

Submit your article

Please submit your article via https://www.editorialmanager.com/YJCPA/default.aspx.

……

更多详情：

https://www.elsevier.com/journals/journal-of-comparative-pathology/0021-9975/guide-for-authors